Press Releases

ABBOTT PARK, Ill., Jan. 3, 2018 — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for the Quadra Assura MPTM Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Fortify AssuraTM Implantable Cardioverter…
DUBLIN — December 19, 2017 — Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic's Asia Pacific (APAC) Region, has been named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group (MITG). In…
San Diego, Calif. — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the company’s lead product candidate,…
Malvern, Pa., December 11, 2017 — Siemens Healthineers has launched teamplay Cardio, a new cardiology dashboard application within the Siemens Healthineers Digital Ecosystem. Part of teamplay—the company’s cloud-based network that enables access to metrics from a facility’s imaging fleet—this…
ROSEMONT, Ill., Dec. 11, 2017 — Eating yogurt on a regular basis may help reduce measures of chronic inflammation in women and support a healthy digestive system, researchers from University of Wisconsin-Madison College of Agricultural and Life Sciences (UW-Madison) report in the British Journal…
PLAINSBORO, N.J., Dec. 5, 2017 — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide) injection 0.5 mg or 1 mg, a once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet…
WALTHAM, MA — December 1, 2017 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center, a leading cardiovascular center located in the Texas Medical Center, has…
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE)—BioTelemetry, Inc., the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple to provide cardiac monitoring…
DUBLIN, Ohio, November 30, 2017 — Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries. The EluNIR™…
MADRID — Nov. 28, 2017 — MedLumics, a medical device company developing an optically guided cardiac ablation platform for the treatment of Atrial fibrillation (AF), announced today it has appointed James Greene as Chief Executive Officer and named Giovanni Leo to the board of directors. The…
HOUSTON (November 16, 2017)—Digisonics and Medis have partnered to provide a comprehensive single system solution that adds cardiac MR to Digisonics congenital Echo and Cath system. The industry leading QMass and QFlow applications from Medis will help solidify Digisonics as the only congenital…
New York, NY (November, 21, 2017) — This Thanksgiving week, WCBS-TV will air “The Resilient Heart,” a feature documentary that explores the keys to eradicating heart disease on a worldwide scale. The film will air on Friday, November 24, from 10 am to 11 am on WCBS (channel 2) and on Sunday,…
DUBLIN — November 20, 2017 — Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology. Available in both single chamber and dual chamber models, the Azure XT MRI and…
TITUSVILLE, N.J., Nov. 17, 2017 — A new real-world analysis of adults with type 2 diabetes and established cardiovascular disease (CVD) shows adult patients who initiated therapy with INVOKANA® (canagliflozin) or another sodium glucose cotransporter-2 inhibitor (SGLT2i) had a 43 percent reduced…
SILVER SPRING, Md., Nov. 16, 2017 — The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors."…
RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 13, 2017 — New data presented today showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and peripheral artery disease. These results, from a post-hoc analysis…
THOUSAND OAKS, Calif., Nov. 13, 2017 — Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular outcomes study (FOURIER) that showed the addition of Repatha to statin therapy improved clinical outcomes with significant reduction of…
Alexandria, VA—The Centers for Medicare & Medicaid Services (CMS) today finalized its rule for the Merit-Based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMs) that AMGA contends will slow the transition to value. In its rule for the Quality Payment Program’s (…
DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance Report. The report highlights the combined financial, social, and environmental impact of Medtronic.The FY2017 Integrated Performance Report details the company's commitment…
DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting showcasing the excellent clinical performance of the Evolut(TM) Transcatheter Aortic Valve Replacement (TAVR) platform. Six-month data…
DUBLIN and DENVER – October 31, 2017 – Medtronic plc (NYSE:MDT) today presented new clinical research to support the positive clinical performance of the Evolut™ Transcatheter Aortic Valve Replacement (TAVR) Platform in intermediate-risk, severe, symptomatic, aortic stenosis patients. Outcomes…